68Ga-FAPI PET/CT in Challenging Thyroid Cancer Cases: Complementary Findings and Interpretive Pitfalls in a Seven-Patient Case Series
Gallium-68 fibroblast activation protein inhibitor (68Ga-FAPI) PET/CT targets cancer-associated fibroblasts and may provide complementary information in challenging thyroid cancer cases. We retrospectively evaluated seven patients with thyroid cancer who underwent 68Ga-FAPI-04 PET/CT between November 2023 and December 2025 for suspected recurrent or metastatic disease or further characterization of known disease. The cohort comprised three males and four females (median age, 39 years; range, 20–81 years) with follicular cell-derived or medullary thyroid carcinoma. Findings were compared descriptively with available anatomical imaging, radioiodine scintigraphy, 18F-FDG PET/CT, and 68Ga-DOTATATE PET/CT. Histopathology and clinical or imaging follow-up were used for lesion characterization where available. FAPI uptake varied substantially, ranging from low uptake in histologically confirmed metastatic follicular thyroid carcinoma (SUVmax 1.5) to intense uptake in a gluteal lesion (early/delayed SUVmax 17.7/32.6) that subsequently regressed metabolically, favoring an inflammatory process. FAPI provided additional lesion characterization in medullary thyroid carcinoma, although a newly identified parapharyngeal lesion remained unconfirmed, and the muscular focus was indeterminate. Discordance with FDG and DOTATATE findings was also observed. 68Ga-FAPI PET/CT may provide complementary information in selected thyroid cancer cases but requires cautious interpretation alongside other imaging, histopathology, and follow-up.
Authors
- Diyaa Juaidi
- Marwah Abdulrahman (ORCID: https://orcid.org/0000-0001-9863-9053)
- Akram Al‐Ibraheem (ORCID: https://orcid.org/0000-0002-0978-4716)
- Saad Ruzzeh (ORCID: https://orcid.org/0009-0003-2916-0905)
- Nouraldeen Alzorgan (ORCID: https://orcid.org/0009-0009-9540-2742)
- Tasneem Alkahder (ORCID: https://orcid.org/0000-0002-1343-8488)
- Noor Abdul Malek
- Hussam Haddad
- Maryam Muthanna
- Soud Al-Qasem
Institutions
- University of Jordan (JO)
- King Hussein Cancer Center (JO)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3390/ijms272210466
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00